HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Use of mannitol.

Abstract
There are two "class 1" studies, and one "class 2" study, and a large body of "Class 3" data, which can be used to support mannitol. The evidence supporting use of mannitol for ICP control is sufficiently strong to warrant guideline status. Mannitol is effective in reducing ICP, and its use is recommended as a guideline in the management of traumatic intracranial hypertension. Serum osmolalities >320 mOsm and hypovolemia should be avoided. There is some data to suggest that bolus administration is preferable to continuous infusion.
Authors
JournalJournal of neurotrauma (J Neurotrauma) 2000 Jun-Jul Vol. 17 Issue 6-7 Pg. 521-5 ISSN: 0897-7151 [Print] UNITED STATES
PMID10937895 (Publication Type: Guideline, Journal Article, Practice Guideline, Review)
Chemical References
  • Diuretics, Osmotic
  • Mannitol
Topics
  • Brain Injuries (drug therapy, physiopathology)
  • Craniocerebral Trauma (drug therapy, physiopathology)
  • Diuretics, Osmotic (therapeutic use)
  • Humans
  • Intracranial Pressure
  • MEDLINE
  • Mannitol (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: